ENDRA Life Sciences Inc (NDRA) Insider Trading
- $252,076.85
- $837,695.47
- Aug. 27, 2024
- Michael Milos Thornton
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Aug. 27, 2024 | Major Shareholder | 3,715 | $0.55 | Buy | $2,043.25 | |
May 18, 2023 | CTO | 15,000 | $1.65 | Buy | $24,750.00 | |
May 2, 2023 | Director | 83,333 | $1.20 | Buy | $99,999.60 | |
Dec. 9, 2022 | CTO | 1,500 | $3.40 | Buy | $5,100.00 | |
Nov. 23, 2022 | Director | 10,000 | $0.17 | Buy | $1,700.00 | |
Aug. 22, 2022 | CTO | 20,000 | $0.27 | Buy | $5,400.00 | |
May 26, 2022 | CTO | 25,000 | $0.21 | Buy | $5,250.00 | |
May 18, 2022 | CTO | 25,000 | $0.22 | Buy | $5,500.00 | |
May 17, 2022 | CEO | 5,100 | $0.19 | Buy | $969.00 | |
Aug. 25, 2021 | Director | 45,000 | $1.83 | Sell | $82,350.00 | |
April 7, 2021 | CTO | 15,000 | $2.53 | Sell | $37,950.00 | |
March 29, 2021 | CTO | 18,750 | $2.37 | Sell | $44,437.50 | |
Jan. 12, 2021 | Insider | 6,304 | $1.05 | Sell | $6,619.20 | |
Jan. 8, 2021 | Insider | 8,731 | $0.94 | Sell | $8,207.14 | |
Jan. 8, 2021 | Director | 10,000 | $0.90 | Sell | $9,000.00 | |
Jan. 6, 2021 | Insider | 11,269 | $0.94 | Sell | $10,592.86 | |
Jan. 5, 2021 | CFO | 100 | $0.90 | Sell | $90.00 | |
Dec. 17, 2020 | Insider | 25,000 | $0.73 | Sell | $18,250.00 | |
Dec. 4, 2020 | CEO | 71,519 | $0.83 | Sell | $59,360.77 | |
Nov. 13, 2020 | Insider | 10,000 | $0.81 | Sell | $8,100.00 | |
Oct. 1, 2020 | Insider | 10,000 | $0.72 | Sell | $7,200.00 | |
June 8, 2020 | Director | 5,000 | $0.91 | Buy | $4,550.00 | |
May 28, 2020 | Director | 10,000 | $0.89 | Buy | $8,900.00 | |
May 26, 2020 | Director | 10,000 | $0.84 | Buy | $8,400.00 | |
May 21, 2020 | Director | 10,000 | $0.71 | Buy | $7,100.00 | |
Sept. 27, 2019 | CFO | 10,000 | $1.18 | Buy | $11,800.00 | |
Aug. 23, 2019 | CFO | 10,000 | $1.56 | Buy | $15,600.00 | |
June 10, 2019 | Director | 500 | $1.14 | Buy | $570.00 | |
June 7, 2019 | Director | 9,500 | $1.11 | Buy | $10,545.00 | |
May 16, 2019 | Insider | 30,000 | $1.13 | Buy | $33,900.00 | |
Oct. 24, 2018 | Major Shareholder | 130,200 | $4.19 | Sell | $545,538.00 |
Insiders are both buying and selling ENDRA Life Sciences Inc stock.
The insider traders at ENDRA Life Sciences Inc are: Michael Milos Thornton, Renaud Bertrand Maloberti, Lou Basenese, David R Wells, Alexander Y Tokman, Anthony Digiandomenico, Francois Roger Michelon, Michael Harsh, Longboard Capital Advisors, Ll, and Group Ag Ubs
The most active insider trader at ENDRA Life Sciences Inc is Michael Milos Thornton with 8 trades.
Longboard Capital Advisors, Ll has sold the most ENDRA Life Sciences Inc stock with a total value of $1,091,076.00.
Anthony Digiandomenico has bought the most ENDRA Life Sciences Inc stock with a total value of $204,549.20.
The most recent insider trade for ENDRA Life Sciences Inc was on Aug. 27, 2024.
The single biggest insider buy for ENDRA Life Sciences Inc was from Anthony Digiandomenico with a total value of $99,999.60 on May 2, 2023.
The single biggest insider sell for ENDRA Life Sciences Inc was from Longboard Capital Advisors, Ll with a total value of $545,538.00 on Oct. 24, 2018.